Literature DB >> 23893245

The male-specific factor Sry harbors an oncogenic function.

S Murakami1, S Chishima1, H Uemoto1, E Sakamoto1, T Sato1, N Kurabe1, Y Kawasaki1, T Shibata2, H Akiyama1, F Tashiro1.   

Abstract

Sgf29, a component of the SPT-ADA-GCN5 acetyltransferase (SAGA) complex, binds H3K4me2/3 marks and leads to histone H3 acetylation. Previously, we found that downregulation of Sgf29 suppresses c-Myc-mediated malignant transformation. Nonetheless, the upstream regulator of the Sgf29 gene is not yet known. Here, we report that Sry (sex-determining region Y), an HMG (high-mobility group) domain containing transcription factor, directly upregulates Sgf29 gene expression. Sry expression was deregulated in two out of the four tested male rodent hepatocellular carcinoma (rHCC) cell lines. Luciferase reporter and chromatin immunoprecipitation assays indicated that Sry could bind HMG-boxes in the proximal promoter region of the Sgf29 gene. Knockdown of Sry robustly lowered anchorage-independent growth, invasiveness and tumorigenicity of rHCC cells, whereas ectopic expression of Sry conferred more malignant properties. Thus, these data show that Sry is involved in male-specific malignant conversion of rHCCs via Sgf29 upregulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893245     DOI: 10.1038/onc.2013.262

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Does the Sex-Determining Region on the Y Chromosome (SRY) Correlate with Gender Disparity in Liver Disease?

Authors:  Xu-Feng Zhang; Yi Lv
Journal:  Dig Dis Sci       Date:  2015-02-10       Impact factor: 3.199

2.  The Y Chromosome Takes the Field to Modify BMPR2 Expression.

Authors:  Andrea L Frump; Tim Lahm
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

Review 3.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

Review 4.  Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.

Authors:  Nico Buettner; Robert Thimme
Journal:  Semin Immunopathol       Date:  2018-11-29       Impact factor: 9.623

Review 5.  Functions of SAGA in development and disease.

Authors:  Li Wang; Sharon Y R Dent
Journal:  Epigenomics       Date:  2014-06       Impact factor: 4.778

Review 6.  SGF29 and Sry pathway in hepatocarcinogenesis.

Authors:  Nobuya Kurabe; Shigekazu Murakami; Fumio Tashiro
Journal:  World J Biol Chem       Date:  2015-08-26

7.  JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis.

Authors:  Na Li; Shilpa S Dhar; Tsai-Yu Chen; Pu-Yeh Kan; Yongkun Wei; Jae-Hwan Kim; Chia-Hsin Chan; Hui-Kuan Lin; Mien-Chie Hung; Min Gyu Lee
Journal:  Cancer Res       Date:  2016-01-08       Impact factor: 12.701

Review 8.  Sexual dimorphism in solid and hematological malignancies.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Lara Meier; Sonja Loges
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 9.  Sexual dimorphism in cancer.

Authors:  Andrea Clocchiatti; Elisa Cora; Yosra Zhang; G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

Review 10.  Let's Talk About Sex-Biological Sex Is Underreported in Biomaterial Studies.

Authors:  Bryan D James; Paxton Guerin; Josephine B Allen
Journal:  Adv Healthc Mater       Date:  2020-10-11       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.